HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenoiate mofetil [1]

AIDS

Volumn 18, Issue 11, 2004, Pages 1607-1608

  Jurriaans, Suzanne ^a   Sankatsing, Sanjay U C ^a   Prins, Jan M ^a   Schuitemaker, Hanneke ^b   Lange, Joep ^a   Van Der Kuyl, Antoinette C ^a   Cornelissen, Marion ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEVIRAPINE; RITONAVIR; VIRUS RNA;

CASE REPORT; CLINICAL FEATURE; GENE DELETION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; TREATMENT OUTCOME; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID;

EID: 3843098208     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000131367.05823.ce     Document Type: Letter

References (19)

1. Lepage P, Van de Perre P., Simonon A, Mseliati P, Hitimana DG, Dabis F. Transient seroreversion in children born to human immunodeficiency virus 1-infected mothers. Pediatr Infect Dis J 1992, 11:892-894.
2. Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hiliyer GV, Diaz C. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J 1995, 14:382-387.
3. Bakshi SS, Tetali S, Abrams EJ, Paul MO, Pahwa SG. Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroreverting infants. Pediatr Infect Dis J 1995, 14:658-662.
4. Gutierrez M, Soriano V, Bravo R, Vallejo A, Gonzalez-Lahoz J. Seroreversion in patients with end-stage HIV infection. Vox Sang 1994, 67:238-239.
5. Roy MJ, Damato JJ, Burke DS. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 1993, 269:2876-2879.
6. Zaaijer HL, Bloemer MH, Lelie PN. Temporary seronegativity in a human immunodeficiency virus type 1-infected man. J Med Virol 1997, 51:80-82.
7. Soriano V, Dronda F, Gonzalez-Lopez A, Chaves F, Bravo R, Gutierrez M, et al. HIV-1 causing AIDS and death in a seronegative individual. Vox Sang 1994, 67:410-411.
8. Martin-Rico P, Pedersen C, Skinhoj P, Nielsen C, Lindhardt BO. Rapid development of AIDS in an HIV-1-antibody-negative homosexual man. AIDS 1995, 9:95-96.
9. Montagnier L, Brenner C, Chamaret S, Guetard D, Blanchard A, de Saint MJ, et al. Human immunodeficiency virus infection and AIDS in a person with negative serology. J Infect Dis 1997, 175:955-959.
10. Reimer L, Mottice S, Schable C, Sullivan P, Nakashima A, Rayfield M, et al. Absence of detectable antibody in a patient infected with human immunodeficiency virus. Clin Infect Dis 1997, 25:98-100.
11. Sankatsing SUC, Jurrians S, van Swieten P, van Leth F, Cornelissen M, Miedema F, et al. Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients. AIDS 2004, in press.
12. Rhodes DI, Ashton L, Solomon A, Carr A, Cooper D, Kaldor J, et al. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term non-progression. Australian Long-Term Nonprogressor Study Group. J Virol 2000, 74:10581-10588.
13. Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, et al. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. J Infect Dis 2001, 184:1465-1469.
14. Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997, 278: 1447-1450.
15. Notermans DW, De Wolf F, Oudshoorn P, Cuijpers HT, Pirillo M, Tiller FW, et al. Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations. AIDS Res Hum Retroviruses 2000, 16:1507-1517.
16. Hutchinson P, Chadban SJ, Atkins RC, Holdsworth SR. Laboratory assessment of immune function in renal transplant patients. Nephrol Dial Transplant 2003, 18:983-989.
17. Hardwick LL, Savatta SC, Book BK, Milgrom ML, McQueen J, Anderson M, et al. Effect of mycophenolate mofetil on the Anti-CMV serologic response after renal transplantation. Transplant Proc 2001, 33:1865-1866.
18. Kimball JA, Pescovitz MD, Book BK, Norman DJ. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil. Transplantation 1995, 60:1379-1383.
19. Rentenaar RJ, van Diepen FN, Meijer RT, Surachno S, Wilmink JM, Schellekens PT, et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 2002, 62:319-328.